Veraxa Biotech Holding AG (VRXA)
VRXA Stock Price Chart
Explore Veraxa Biotech Holding AG interactive price chart. Choose custom timeframes to analyze VRXA price movements and trends.
VRXA Company Profile
Discover essential business fundamentals and corporate details for Veraxa Biotech Holding AG (VRXA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Jun 2026
Employees
8.00
Website
https://www.veraxa.comCEO
Christoph Antz
Description
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]
VRXA Financial Timeline
Browse a chronological timeline of Veraxa Biotech Holding AG corporate events including earnings releases, dividend announcements, and stock splits.
VRXA Stock Performance
Access detailed VRXA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
